Global Tumor Markers Testing Market By Types (Human Chorionic Gonadotropin (HCG or b-HCG), Cancer Antigen 15-3 (CA15-3), Alpha-Fetoprotein (AFP), Carbohydrate Antigen 19-9 (CA19-9), Cancer Antigen 125 (CA125), Carcinoembryonic Antigen (CEA), Prostate-Specific Antigen (PSA)), Organ (Bladder, Breast, Colorectal, Gastrointestinal, Liver, Lung, Oral, Ovarian, Pancreatic, Prostatic, Skin Testicular Cancer, Leukemia, Lymphoma, Others), End- Users (Hospitals, Commercial/Private Laboratories, Physician Offices/Group Practices, Ambulatory Care Centers), Products (Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains, Others), Methods (Screening, Imaging, Theranostics, Signoidoscopy, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026
Market Analysis: Global Tumor Markers Testing Market
Global tumor markers testing market is set to witness a stable CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. Rising cases of cancer worldwide and rising research on tumor marker is the major factors fueling the growth of this market.